Skip to main content
. 2020 Mar 20;21:72. doi: 10.1186/s12931-020-1329-y

Fig. 5.

Fig. 5

Key pathophysiological pathways significantly modulated by CHF6001 in sputum with associated inhibition of downstream inflammatory effectors. Created with Biorender.com